维持性血液透析患者冠状动脉钙化相关血清学标志物的筛选及其相关性分析
作者:
作者单位:

(西南医科大学附属医院肾病内科 四川省肾脏疾病临床医学研究中心,四川省泸州市 646000)

作者简介:

郭文利,硕士,研究方向为肾脏病学,E-mail:1432937743@qq.com。通信作者欧三桃,博士,主任医师,研究方向为慢性肾脏病血管钙化,E-mail:ousantao@163.com。

基金项目:

四川省肾脏疾病临床医学研究中心2020年开放课题重点项目(2019YFS0537-3)


Screening and correlation analysis of serum markers related to coronary artery calcification in maintenance hemodialysis patients
Author:
Affiliation:

Department of Nephrology, Affiliated Hospital of Southwest Medical University & Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan 646000, China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的]分析维持性血液透析(MHD)患者冠状动脉钙化(CAC)的临床特点,并寻找用于评估CAC的无创血清学标志物。 [方法]选取MHD患者148例,根据多层螺旋CT(MSCT)并采用冠状动脉钙化积分(CACS)评估CAC情况。根据CACS将MHD患者分成3组(CACS<100组、100≤CACS≤400组、CACS>400组),比较三组患者一般临床资料及血清鸢尾素、骨硬化蛋白(SOST)、低氧诱导因子1α(HIF-1α)、胎球蛋白A等的差异;采用Spearman相关分析CAC程度与各指标的相关性;采用Logistic回归分析MHD患者CAC的独立影响因素;采用受试者工作特征(ROC)曲线寻找用于诊断和评估CAC的无创血清学指标。 [结果]148例MHD患者中CAC(CACS>100)的患病率为62.8%(93/148);三组患者的年龄、血磷、总胆固醇、甘油三酯、低密度脂蛋白胆固醇、尿酸、血清鸢尾素及SOST水平有显著差异(P<0.05),而HIF-1α、胎球蛋白A水平无显著差异(P>0.05)。Spearman相关分析显示,CAC程度与年龄、体质指数、总胆固醇、甘油三酯、低密度脂蛋白胆固醇、血磷、钙磷乘积、血清SOST水平呈正相关(P<0.05),与鸢尾素水平呈负相关(P<0.05)。Logistic回归分析显示,高龄、高甘油三酯、高SOST、低鸢尾素为中重度CAC的独立危险因素(P<0.05)。ROC曲线分析发现,鸢尾素、SOST对MHD患者并发CAC具有较高的诊断价值。 [结论]血清鸢尾素、SOST可望成为诊断和评估CAC严重程度的血清学指标。

    Abstract:

    Aim To analyze the clinical characteristic of coronary artery calcification (CAC) in patients with maintenance hemodialysis (MHD) and search for noninvasive serological markers for evaluating CAC. Methods 148 MHD patients were selected as the research subjects. The coronary artery calcification score (CACS) was evaluated by multi-slice spiral CT (MSCT) to judge the CAC status. According to CACS, patients with MHD were divided into three groups (CACS<100 group, 100≤CACS≤400 group, CACS>400 group). Compare the differences of serum irison, sclerostin (SOST), hypoxia inducible factor-1α (HIF-1α), fetuin A and general clinical data in the three groups. Spearman correlation was used to analyze the correlation between the degree of CAC and each index. Logistic regression analysis was used to analyze the risk factor of CAC in MHD patients. Receiver operating characteristic (ROC) curve was used to search for non-invasive serological indicators for diagnosis and evaluation of CAC in MHD patients. Results The prevalence of CAC (CACS>100) in 148 MHD patients was 62.8% (93/148). There were statistical differences in irisin, SOST, serum phosphate, age, total cholesterol, triglyceride, low density lipoprotein cholesterol and uric acid among the three groups (P<0.05), while there were no differences in HIF-1α and fetuin A (P>0.05). Spearman correlation analysis showed that the degree of CAC was positively correlated with SOST, age, body mass index, total cholesterol, triglyceride, low density lipoprotein cholesterol, blood phosphorus, calcium-phosphorus product (P<0.05), and negatively correlated with the level of irisin (P<0.05). Multivariate Logistic regression analysis showed that serum triglyceride, SOST and irison level was independent risk factor for CAC(P<0.05). ROC curve analysis showed that irisin and SOST had high diagnostic value for MHD patients complicated with CAC. Conclusion Serum irisin and SOST are expected to be non-invasive serological indicators for the diagnosis and evaluation of the severity of CAC.

    参考文献
    [1] CANO-MEGAS M, GUISADO-VASCO P, BOUARICH H, et al.Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease:a prospective long-term follow-up study.BMC Nephrol, 9,0(1):188.
    [2] LIU Z H, YU X Q, YANG J W, et al.Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis:baseline results from a prospective cohort study.Curr Med Res Opin, 8,4(8):1491-1500.
    [3] GOMARASCA M, BANFI G, LOMBARDI G.Myokines:the endocrine coupling of skeletal muscle and bone.Adv Clin Chem, 0,4:155-218.
    [4] DREKE T B, LAFAGE-PROUST M H.Sclerostin:just one more player in renal bone disease?.Clin J Am Soc Nephrol, 1,6(4):700-703.
    [5] BALOGH E, TTH A, MHES G, et al.Hypoxia triggers osteochondrogenic differentiation of vascular smooth muscle cells in an HIF-1 (hypoxia-inducible factor 1)-dependent and reactive oxygen species-dependent manner.Arterioscler Thromb Vasc Biol, 9,9(6):1088-1099.
    [6] XIAO D M, WU Q, FAN W F, et al.Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients.Hemodial Int, 3,7(4):483-492.
    [7] KOMATSU M, OKAZAKI M, TSUCHIYA K, et al.Aortic arch calcification predicts cardiovascular and all-cause mortality in maintenance hemodialysis patients.Kidney Blood Press Res, 4,9(6):658-667.
    [8] ZENG C, GUO C Y, CAI J, et al.Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease.Diab Vasc Dis Res, 8,5(2):99-105.
    [9] BRANDENBURG V M, KRAMANN R, KOOS R, et al.Relationship between sclerostin and cardiovascular calcification in hemodialysis patients:a cross-sectional study.BMC Nephrol, 3,4:219.
    [10] NIGWEKAR S U, THADHANI R, BRANDENBURG V M.Calciphylaxis.N Engl J Med, 8,8(18):1704-1714.
    [11] 卢俊颜, 向光大, 梅稳, 等.鸢尾素通过激活3-磷酸磷脂酰肌醇激酶-蛋白激酶B-内皮型一氧化氮合酶信号转导途径抗高糖诱导的人脐静脉内皮细胞凋亡.中华糖尿病杂志, 2015(6):355-361.LU J Y, XIANG G D, MEI W, et al.Irisin prevents high glucose-induced human umbilical vein endothelial cell apoptosis via phosphatidylinositol-3-kinase-protein kinase B-endothelial nitric oxide synthase signaling pathway.Chin J Diabetes Mellitus, 2015(6):355-361.
    [12] QIAO X Y, NIE Y, MA Y X, et al.Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways.Sci Rep, 6,6:18732.
    [13] HE W Y, WU F, PANG X X, et al.Irisin is associated with urotensin Ⅱ and protein energy wasting in hemodialysis patients.Kidney Blood Press Res, 6,1(1):78-85.
    [14] HE L, HE W Y, YANG W L, et al.Lower serum irisin levels are associated with increased vascular calcification in hemodialysis patients.Kidney Blood Press Res, 8,3(1):287-295.
    [15] WEN M S, WANG C Y, LIN S L, et al.Decrease in irisin in patients with chronic kidney disease.PLoS One, 3,8(5):e64025.
    [16] HISAMATSU T, MIURA K, ARIMA H, et al.Relationship of serum irisin levels to prevalence and progression of coronary artery calcification:a prospective, population-based study.Int J Cardiol, 8,7:177-182.
    [17] CSIKY B, SGI B, EMMERT V, et al.Cardiometabolic effects of irisin in patients with end-stage renal disease on regular hemo- or peritoneal dialysis.Blood Purif, 2,1(5):450-457.
    [18] FIGUREK A, RROJI M, SPASOVSKI G.Sclerostin:a new biomarker of CKD-MBD.Int Urol Nephrol, 0,2(1):107-113.
    [19] VERVLOET M G, MASSY Z A, BRANDENBURG V M, et al.Bone:a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.Lancet Diabetes Endocrinol, 4,2(5):427-436.
    [20] CHAPURLAT R D, CONFAVREUX C B.Novel biological markers of bone:from bone metabolism to bone physiology.Rheumatology (Oxford), 6,5(10):1714-1725.
    [21] LV W, GUAN L N, ZHANG Y, et al.Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4.Int Urol Nephrol, 6,8(12):2043-2050.
    [22] ZOU Y, YANG M, WANG J, et al.Association of sclerostin with cardiovascular events and mortality in dialysis patients.Ren Fail, 0,2(1):282-288.
    [23] DE MAR A, OPDEBEECK B, NEVEN E, et al.Sclerostin protects against vascular calcification development in mice.J Bone Mineral Res, 2,7(4):687-699.
    [24] COLAIANNI G, CUSCITO C, MONGELLI T, et al.The myokine irisin increases cortical bone mass.Proc Natl Acad Sci U S A, 5,2(39):12157-12162.
    [25] KIM H, WRANN C D, JEDRYCHOWSKI M, et al.Irisin mediates effects on bone and fat via αV integrin receptors.Cell, 8,5(7):1756-1768.e17.
    [26] SAADELDIN M K, ELSHAER S S, EMARA I A, et al.Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type Ⅱ diabetic female patients:a case control study.PLoS One, 8,3(11):e0206761.
    引证文献
引用本文

郭文利,熊琳,吴蔚桦,杨鑫,康婷,张丽玲,欧三桃.维持性血液透析患者冠状动脉钙化相关血清学标志物的筛选及其相关性分析[J].中国动脉硬化杂志,2023,31(4):336~342.

复制
分享
文章指标
  • 点击次数:1224
  • 下载次数: 1558
历史
  • 收稿日期:2022-04-13
  • 最后修改日期:2022-10-14
  • 在线发布日期: 2023-04-06